Interleukin-1 Blockers
- Name
- Interleukin-1 Blockers
- Accession Number
- DBCAT005688
- Description
Not Available
- Drugs
Drug Drug Description Rilonacept An IL-1 inhibitor used to treat cryopyrin-associated periodic syndrome, a rare hereditary inflammatory disorder. Canakinumab An interleukin-1β blocker used to treat Periodic Fever Syndromes such as Cryopyrin-Associated Periodic Syndromes (CAPS) and Familial Mediterranean Fever (FMF), and also to treat active Systemic Juvenile Idiopathic Arthritis (SJIA). - Drugs & Drug Targets
Drug Target Type Rilonacept Interleukin-1 beta target Rilonacept Interleukin-1 alpha target Rilonacept Interleukin-1 receptor antagonist protein target Canakinumab Interleukin-1 beta target